Armata Pharmaceuticals (ARMP) Dividends payables (2015 - 2018)
Armata Pharmaceuticals (ARMP) posted Dividends payables of $38000.0 for Q4 2018, little changed sequentially from $38000.0 in Q4 2017, and little changed YoY from $38000.0 in Q4 2017.
Armata Pharmaceuticals (ARMP) Dividends payables (2015 - 2018) Analysis & Trends
Armata Pharmaceuticals has reported Dividends payables for 4 years, with the latest figure at $38000.0 in Q4 2018.
- Quarterly Dividends payables changed 0.0% year-over-year to $38000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $38000.0 (changed 0.0% YoY) and the FY2018 annual result came in at $38000.0, changed 0.0% from the prior year.
- Dividends payables was little changed at $38000.0 in Q4 2018 per ARMP's latest filing, from $38000.0 in the prior quarter.
- Over five years, Dividends payables peaked at $970000.0 in Q2 2016 and troughed at $38000.0 in Q4 2016.
- A 4-year average of $282166.7 and a median of $84500.0 in 2015 frame the typical range for Dividends payables.
- The sharpest annual moves came in 2016 and 2017: Dividends payables soared 640.46% in 2016, then sank 96.08% in 2017.
- Over 4 years, Dividends payables stood at $368000.0 in 2015, then plunged by 89.67% to $38000.0 in 2016, then changed by 0.0% to $38000.0 in 2017, then changed by 0.0% to $38000.0 in 2018.
- According to Business Quant data, Dividends payables over the past three periods registered $38000.0, $38000.0, and $38000.0 for Q4 2018, Q4 2017, and Q3 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 38,000.00 |
| Dec 31, 2017 | 38,000.00 |
| Sep 30, 2017 | 38,000.00 |
| Jun 30, 2017 | 38,000.00 |
| Mar 31, 2017 | 38,000.00 |
| Dec 31, 2016 | 38,000.00 |
| Sep 30, 2016 | 953,000.00 |
| Jun 30, 2016 | 970,000.00 |
| Mar 31, 2016 | 368,000.00 |
| Dec 31, 2015 | 368,000.00 |
| Sep 30, 2015 | 368,000.00 |
| Jun 30, 2015 | 131,000.00 |